Clinical Trial Meeting on "Manufacturing Porous and Absorbable Artificial Bone with Additives"

Date of issue:

2023-07-09

Views:

On July 9, 2023, the clinical first research meeting of the 'Additive Manufacturing Porous Absorbable Artificial Bone' project of T-Bright (Kunshan) Biotechnology Co., Ltd. was successfully held at the Novotel Hotel in Kunshan.


The project has basically completed all laboratory research work, passed all 10 biocompatibility tests and product type inspections, obtained valid data from animal experiments for one and a half years, and completed one scientific research clinical trial.


The six clinical trial institutions participating in the first research meeting were: the First Affiliated Hospital of Suzhou University (team leader), the Fourth Medical Center of 301 Hospital, the Sixth People's Hospital of Shanghai Jiaotong University, the Ninth People's Hospital of Shanghai Jiaotong University, Quzhou People's Hospital, and Lishui People's Hospital.


The attending experts had a serious and thorough exchange and discussion about the clinical trial plan, and reached a consensus. CRO company will summarize the opinions to form the final clinical trial plan and officially implement the human clinical trial as soon as possible.


Clinical Trial Meeting on

Clinical Trial Meeting on

Clinical Trial Meeting on

Clinical Trial Meeting on





Recommend

T-Bright Biotechnology settled in Suzhou Industrial Park Weili Medical Science and Innovation Park
In order to lay out the 3D pri...
2023 Golden Autumn Youth League Building Activities Successfully Held
On October 27, 2023, the Daiqu...
T-Bright Biotechnology Won Third Prize in the Final of the 6th China Medical Device Competition
The China Medical Device Innov...
Leaders from the National Drug Administration come to our company for research and exchange work
On the morning of July 20, 202...